REAL-WORD CLINICAL CHARACTERIZATION OF METASTATIC HORMONE SENSITIVE PROSTATE CANCER: DATA FROM THE EUROPEAN NETWORK OF EXCELLENCE FOR BIG DATA IN PROSTATE CANCER (PIONEER)

被引：0
|
作者：
Nicoletti, Rossella
Rivas, Juan Gomez
Ibanez, Laura
Steinbeisserc, Carl
de Meulder, Bertrand
Golozar, Asieh
Axelsson, Susan Evans
Snijder, Robert
Bjartell, Anders
Cornford, Philip
Van Hemelrijck, Mieke
Beyer, Katharina
Willemse, Peter-Paul
Murtola, Teemu
Robool, Monique J.
Sierra, Jesus Moreno
Campi, Riccardo
Gacci, Mauro
Mottet, Nicolas
Merseburger, Axel
Ndow, James
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
10.1097/01.JU.0001009428.69695.82.08
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP14-08
引用
收藏
页码：E222 / E222
页数：1
相关论文
共 50 条
  • [31] Network meta-analysis of combination strategies in metastatic hormone-sensitive prostate cancer
    Wang, Shan-Shan
    Bian, Xiao-Jie
    Wu, Jun-Long
    Wang, Bei-He
    Zhang, Sheng
    Ye, Ding-Wei
    ASIAN JOURNAL OF ANDROLOGY, 2024, 26 (04) : 402 - +
  • [32] Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literature
    Gravis, Gwenaelle
    Audenet, Francois
    Irani, Jacques
    Timsit, Marc Olivier
    Barthelemy, Philippe
    Beuzeboc, Philippe
    Flechon, Aude
    Linassier, Claude
    Oudard, Stephane
    Rebillard, Xavier
    Richaud, Pierre
    Roupret, Morgan
    Vuillemin, Antoine Thiery
    Vincendeau, Sebastien
    Albiges, Laurence
    Rozet, Francois
    CANCER TREATMENT REVIEWS, 2017, 55 : 211 - 217
  • [33] It Is Time to Harmonize the Design and Conduct of Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer
    Sridhar, Srikala S.
    Sweeney, Christopher J.
    EUROPEAN UROLOGY, 2016, 70 (02) : 263 - 264
  • [34] Quantifying Clinical Utility of Enzalutamide for Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer
    Sun, Ryan
    Wei, Lee-Jen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (36) : 4278 - +
  • [35] TMPRSS2-ERG expression and clinical evolution of metastatic hormone sensitive prostate cancer
    Aversa, C.
    Jimenez, N.
    Marin-Aguilera, M.
    Ferrer, L.
    Rodriguez-Carunchio, L.
    Diaz-Mercedes, S.
    Font Pous, A.
    Rodriguez-Vida, A.
    Domenech Santasusana, M.
    Figols Gorina, M.
    Climent Duran, M. A.
    Cros Costa, S.
    Chirivella, I.
    Herrero Rivera, D.
    Gonzalez-Billalabeitia, E.
    Jimenez-Peralta, D.
    Carles Galceran, J.
    Suarez Rodriguez, C.
    Reig Torras, O.
    Mellado, B.
    ANNALS OF ONCOLOGY, 2021, 32 : S661 - S662
  • [36] The incidence, mortality and clinical characteristic of metastatic hormone-sensitive prostate cancer in Asian population
    Thepsarttra, Tanasarit
    Chansriwong, Phichai
    ANNALS OF ONCOLOGY, 2022, 33 : S497 - S497
  • [37] Response pattern to chemotherapy in metastatic breast cancer (MBC): Real-word data from the Austrian AGMT_MBC-Registry
    Rinnerthaler, Gabriel
    Gampenrieder, Simon P.
    Tinchon, Christoph
    Petzer, Andreas Petzer
    Balic, Marija
    Sonja, Heibl
    Zabernigg, August F.
    Egle, Daniel
    Sandholzer, Margit
    Roitner, Florian
    Andel, Johannes
    Pichler, Petra
    Hager, Christophe
    Hubalek, Michael
    Knauer, Michael
    Singer, Christian F.
    Greil, Richard
    CANCER RESEARCH, 2022, 82 (04)
  • [38] Role of Radical Prostatectomy in Metastatic Prostate Cancer: Data from the Munich Cancer Registry
    Gratzke, Christian
    Engel, Jutta
    Stief, Christian G.
    EUROPEAN UROLOGY, 2014, 66 (03) : 602 - 603
  • [39] Cabazitaxel for metastatic castration-resistant prostate cancer (mCRPC) real data in real life
    Manneh Kopp, R.
    Alonso Gordoa, T.
    Celiz, P.
    Sepulveda, J. M.
    Grande, E.
    CastellanoGauna, D.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S499 - S500
  • [40] Contemporary treatment standards and trends of systemic therapy in metastatic hormone-sensitive prostate cancer-implementing study data in clinical practice
    Wenzel, Mike
    Banek, Severine
    Chun, Felix K. H.
    Mandel, Philipp
    UROLOGIE, 2024, 63 (12): : 1259 - 1265
12345